Studies of Cyclodextrin Inclusion Complexes: I - Inclusion Complexes Between α- And β-Cyclodextrins and Chloramphenicol in Aqeuous Solutions

References

• Otagiri M., Imai T., Hirayama F., Uekama K. Inclusion complex formations of the antiinflamatory drug Flurbiprofen with cyclodextrins in aqueous solution and in solid state. Acta Pharm. Suec. 1983; 20: 11–20
   Google Scholar
• Thakkar A. L., Demarco P. V. Cycloheptaamylose Inclusion Complexes of barbiturates: Correlation between Proton Magnetic Resonance and Solubility Studies. J. Pharm, Sci. 1971; 60: 652–653
   PubMed Web of Science ®Google Scholar
• Thoma J. A., Stewart Starch L. Chemistry and Technology, R. L. Whistler, E. F. Paschall. Academic, New York, N. Y. 1965; Vol. I.: 209
   Google Scholar
• Frank S. G., Cho M. J. Phase Solubility analysis and PMR study of Complexing Behaviour of Dinoprostone with β-cyclodextrin in water. J. Pharm. Sci. 1978; 57: 1665–1688
   Google Scholar
• Bender M. L., Komiyama M. Cyclodextrin Chemistry. Springer-Verlag, Berlin 1975
   Google Scholar
• Frank S. G., Kavaliunas D. R. Investigation of the B-cyclodextrin-Hydrocortisone Inclusion Compound. J. Pharm. Sci. 1953; 72: 1215–1217
   Google Scholar
• Nakai Y., Yamamoto K., Terada K., Horibe H., Ozawa K. Interaction of Tri-O-Methyl-B-Cyclodextrin with drugs. II. Enhanced Bioavailability of ketoprofen in Rats when administered with Tri-O-methyl-B-cyclodextrin. Chem. Pharm. Bull. 1983; 31: 3745–3747
   PubMed Web of Science ®Google Scholar
• Uekama K., Hirayama F., Fujise A., Inaba M., Otagiri K., Saito H. Inclusion Complexation of Prostaglandin F2å with γ-cyclodextrin in solution and solid phases. J. Pharm. Sci. 1984; 73: 382–384
   PubMed Web of Science ®Google Scholar
• Fuzy M., Szente L., Szejtli J., Harangi J. Cyclodextrin-Stabilized volatile substances for inhalation therapy. Pharmazie 1984; 39: 558–559
   PubMed Web of Science ®Google Scholar
• Szejtli J. Cyclodextrins and their Inclusion Complexes. Alademiai Kiado, Budapest 1982; 227
   Google Scholar
• Katal M., Antal A. Enhancement of Solubility of Furosemide with B-cyclodextrin. Pharmazie 1984; 39: 856–857
   PubMed Web of Science ®Google Scholar
• Katal M., Lukacs M. Preparation and investigation of Hydrochlorothiazide products containing β-cyclodextrin. Pharmazie 1984; 30: 857–558
   Google Scholar
• Szente L., Gal-Fuzy M., Szejtli J. Proc. 1st Inst. Sympos. on cyclodextrins. Akademiai Kiado, Budapest 1982; 431
   Google Scholar
• Ilonahabon S. Fritsch, Szejtli J. Simulation of pharmacokinetic behaviour of Drug Cyclodextrin Complexes. Pharmazie 1984; 39: 330–834
   Google Scholar
• Jones S. P., Grant D. J. W., Hadgraft J., Parr G. D. Cyclodextrins in pharmaceutical sciences, Part I-preparation, structure and properties of cyclodextrins and cyclodextrin Inclusion compounds. Acta Pharmaceutica Technologica 1984; 30: 215–218
   Google Scholar
• Fenyvesi E., Szejtli K., Takayama J., Najai T. Evaluation of Cyclodextrin polymer as an additive for Furosemide Tablet. Chem. Pharm. Bull. 1984; 32: 670–677
   PubMed Web of Science ®Google Scholar
• Fenyvest E., Antal B., Zsadon B., Szejtali J. Cyclodextrin Polymer, a new Tablet Disintegrating Agent. Pharmazie 1984; 20: 473–476
   Google Scholar
• Fenyvest E., Shirakura O., Szejtli J., Najai T. Properties of cyclodextrin Polymer as a tabletting aid. Chem. Pharm. Bull. 1984; 32: 665–669
   PubMed Web of Science ®Google Scholar
• Nakajima T., Sunagawa M., Hirohashi T., Fujioka K. Abstracts of papers. the 101st Annual Meeting of the pharmaceutical society of Japan, Kumomoto, April, 1981; 625
   Google Scholar
• Nakajima T., Sunagawa M., Matsumura K., Hirohashi T., Natori M., Aono S., Fujioka K., Yamamura Y. (1981) Abstracts of papers. the 3rd symposium on Medicinal Chemistry., Osaka, November, 1981, 13
   Google Scholar
• Nakajima T., Sunagawa M., Hirohashi T., Fujioka K. Studies of cyclodextrin Inclusion Complexes. I. Complex between cyclodextrins and Bencyclane in aqueous solution. Chem. Pharm. Bull. 1954; 32: 383–400
   Google Scholar
• Nakajima T., Sunagawa M., Hirohashi T. Studies of Cyclodextrin Inclusion Complexes. II. Application of the paritition coefficient method. Pharm. Ind. 1984; 32: 408
   Google Scholar
• Abdel Rahman A. A. Investigation Chloramphenicol solubilized systems. University of Assiut. 1978, M.Sc. Thesis.
   Google Scholar
• Higuchi T, Lach J. L. J. Am. Pharm. Assoc. Sci. Ed. 1954; 459
   Google Scholar
• Uekama K., Hirayama F., Esaki K., Inoue M. Inclusion Complexes of cyclodextrins with cinnamic acid Derivatives: Dissolution and Thermal behaviour. Chem. Pharm. Bull. 1979; 27: 76–79
   Web of Science ®Google Scholar
• Wong A. B., Lin S-F., Connors K. A. Stability Constants for complex formation between α-cycloedextrin and Some. Amines. J. Pharm. Sci. 1983; 72: 388–390
   PubMed Web of Science ®Google Scholar
• Uekama K., Fujinaga T., Otagiri M. Improvement of dissolution and chemical stability of proscillaridin by cyclodextrin complexation. Acta Pharm. Suec. 1983; 20: 287–294
   Google Scholar
• Uekama K., Narisaw S., Hirayama F., Otagiri M. Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexatior. International Journal of Pharmaceutcics 1983; 16: 327–333
   Web of Science ®Google Scholar
• Uekama K., Uemura Y., Irie T., Otagiri M. Analysis of Interfacial Transfer and Absorption Behaviour of Drugs Following Dissolution from β-cyclodextrin Complexes. Chem. Pharm. Bull. 1983; 31: 3637–3643
   PubMed Web of Science ®Google Scholar
• Anderson F. M., Bundgaard H. Inclusion complexation of disulfiram with cyclodextrins to enhance aqueous solubility. Arch. Pham. Chem. Sci. Ed. 1984; 12: 17–25
   Google Scholar
• Higuchi T., Connors K. A. Ad. Anal. Chem. Instr. 1965; 4: 117
   Google Scholar
• Anderson F. M., Bundgaard H. The influence of B-cyclodextrin on the stability of Hydrocortisone in aqueous solution. Arch. Pharm. Chem., Sci., Ed. 1983; 11: 61–66
   Google Scholar
• Uekama K., Fujinaga T., Hirayama F., Otagin M., Yamasaki M. Int. J. Pharm. 1982; 10: 1
   Web of Science ®Google Scholar